Envista Corp

NYSE: NVST · Real-Time Price · USD
16.38
-0.59 (-3.48%)
At close: May 06, 2025, 3:59 PM
16.39
0.09%
After-hours: May 06, 2025, 06:01 PM EDT

Company Description

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions.

The company is headquartered in Brea, California and currently employs 12,800 full-time employees.

The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone.

The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables.

Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products.

Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

Envista Corp
Envista  Corp logo
Country United States
IPO Date Sep 18, 2019
Industry Medical - Equipment & Services
Sector Healthcare
Employees 12,300
CEO Paul A. Keel

Contact Details

Address:
200 S Kraemer Blvd Bldg E
Brea, California
United States
Website http://www.envistaco.com/

Stock Details

Ticker Symbol NVST
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001757073
CUSIP Number 29415F104
ISIN Number US29415F1049
Employer ID 83-2206728
SIC Code 3843

Key Executives

Name Position
Paul A. Keel Chief Executive Officer & Director
Andrew Chen Chief Information Officer
Eric D. Hammes Senior Vice President & Chief Financial Officer
Faez Kaabi Vice President, Chief Accounting Officer & Corporate Controller
Filippo Impieri Senior Vice President of Emerging Markets
Mark E. Nance J.D. Senior Vice President, General Counsel & Secretary
Mischa M. Reis Senior Vice President of Strategy & Corporate Development
Paul Sumilas Chief Compliance Officer
Robert Befidi Jr. President of Diagnostics
Suraj Satpathy Chief Human Resources officer

Latest SEC Filings

Date Type Title
May 01, 2025 10-Q Quarterly Report
May 01, 2025 8-K Current Report
Apr 24, 2025 ARS Filing
Apr 24, 2025 DEFA14A Filing
Apr 24, 2025 DEF 14A Filing
Apr 17, 2025 SCHEDULE 13G/A [Amend] Filing
Feb 27, 2025 4 Filing
Feb 27, 2025 4 Filing
Feb 27, 2025 4 Filing
Feb 27, 2025 4 Filing